Self-assembling chitosan/poly-γ-glutamic acid nanoparticles for targeted drug delivery

Colloid and Polymer Science

Volumn 287, Issue 7, 2009, Pages 759-765

  Keresztessy, Zsolt ^a   Bodnár, Magdolna ^a   Ber, Elizabeth ^b   Hajdu, István ^a   Zhang, Min ^b   Hartmann, John F ^c   Minko, Tamara ^b   Borbély, János ^d  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b RUTGERS UNIVERSITY   (United States)

^c ElizaNor Polymer LLC   (United States)

^d BBS NANOTECHNOLOGY LTD   (Hungary)

Author keywords

Cellular uptake; Chitosan; Cytotoxicity; In vivo toxicity; Nanoparticles; PGA; Poly glutamic acid

Indexed keywords

ANIMAL FEEDING; ANTI-CANCER AGENTS; AQUEOUS ENVIRONMENT; BIODEGRADABLE NANOPARTICLE; CANCER CELLS; CELL BOUNDARY; CELLULAR UPTAKE; CONFOCAL MICROSCOPIC IMAGING; CYTOPLASMIC DELIVERY; DIGITAL PROCESSING; FOLATE RECEPTOR; FOLIC ACIDS; GLUTAMIC ACID; GREEN COLOR; IN VIVO TOXICITY; INTRACELLULAR DRUG DELIVERY; IONOTROPIC GELATION; NON-TARGETED; OVARIAN CANCER CELLS; PGA; QUANTITATIVE DATA; SELF ASSEMBLED NANOPARTICLES; SELF-ASSEMBLING; SMOOTH SURFACE; SPHERICAL PARTICLE; TARGETED DRUG DELIVERY;

ANIMAL CELL CULTURE; ATOMIC FORCE MICROSCOPY; CELL MEMBRANES; CHITIN; CHITOSAN; COAGULATION; CYTOTOXICITY; DIFFERENTIAL AMPLIFIERS; DRUG DELIVERY; GELATION; NANOPARTICLES; NANOSYSTEMS; ORGANIC ACIDS; PROGRAMMED CONTROL SYSTEMS; TRANSMISSION ELECTRON MICROSCOPY;

CELL CULTURE;

CHITOSAN; FOLIC ACID; NANOPARTICLE; POLY GAMMA GLUTAMIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER CELL CULTURE; CELL TRANSPORT; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; INTERNALIZATION; MOUSE; NANOENGINEERING; NONHUMAN; OVARY CANCER; POLYMERIZATION; PRIORITY JOURNAL; TOXICITY TESTING;

EID: 67349138636     PISSN: 0303402X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00396-009-2022-3     Document Type: Article

References (32)

1. McNeil SE (2005) Nanotechnology for the biologists. J Leukocyte Biol 78:585-594
2. Majoros IJ, Thomas T, Baker JR Jr (2006) Molecular engineering in nanotechnology: Engineered drug delivery. In: Reith M, Schommers W (eds) Handbook of theoretical and computational nanotechnology, vol 6. American Scientific, Stevenson Ranch, CA, pp 673-717
3. Vicent MJ, Duncan R (2006) Polymer conjugates: Nanosized medicines for treating cancer. Trends Biotech 24:39-47
4. Duncan R (2003) The dawning era of polymer therapeutics. Nat Rev Drug Discover 2:347-360
5. Nobs L, Buchegger F, Gurny R, Allémann E (2006) Biodegradable nanoparticles for direct and two-step tumor immunotargeting. Bioconj Chem 17:139-145
6. Torchilin VP (2006) Multifunctional nanocarriers. Adv Drug Del Rev 58:1532-1555
7. Ulbrich K, Subr V (2004) Polymeric anticancer drugs with pH-controlled activation. Adv Drug Deliv Rev 56:123-1050
8. Sawant RM, Hurley JP, Salmaso S, Kale A, Tolcheva E, Levchenko TS, Torchilin VP (2006) "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconj Chem 17:943-949
9. Grodzinsky P, Silver M, Molnar LM (2006) Nanotechnology for cancer diagnostics: Promises and challenges. Expert Rev Mol Diagn 6:307-318
10. Khan MK, Nigavekar SS, Minc LD, Kariapper MST, Nair BM, Lesniak WG, Balogh LP (2005) In vivo biodistribution of dendrimers and dendrimer nanocomposites - implications for cancer imaging and therapy. Technol Cancer Res Threat 4:603-613
11. Hajdu I, Bodnar M, Filipcsei G, Hartmann JF, Daroczi L, Zrinyi M, Borbely J (2008) Nanoparticles prepared by self-assembly of chitosan and poly-γ-glutamic acid. Coll Polym Sci 286:343-350
12. Berger J, Reist M, Mayer JM, Felt O, Gurny R (2004) Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications. Eur J Pharm Biopharm 57:35-52
13. Hsieh C-Y, Tsai S-P, Wang D-M, Chang Y-N, Hsieh H-J (2005) Preparation of γ-PGA/chitosan composite tissue engineering matrices. Biomaterials 26:5617-5623
14. Lin Y-H, Chung CK, Chen C-T, Liang H-F, Chen S-C, Sung H-W (2005) Preparation of nanoparticles composed of chitosan/poly-g-glutamic acid and evaluation of their permeability through caco-2 cells. Biomacromolecules 6:1104-1112
15. Lin Y-H, Mi F-L, Chen C-T, Chang W-C, Peng S-F, Liang H-F, Sung H-W (2007) Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules 8:146-152
16. Lin WC, Yu DG, Yang MC (2006) Blood compatibility of novel poly(γ-glutamic acid)/polyvinyl alcohol hydrogels. Colloid Surface B 47:43-49
17. Krecz A, Pocsi I, Borbely J (2001) Preparation and chemical modification of poly-gamma-L-glutamic acid. Folia Microbiol 46:183-186
18. Borbely M, Nagasaki Y, Borbely J, Fan K, Bhogle A, Sevoian M (1994) Biosynthesis and chemical modification of poly(gamma-glutamic acid). Polym Bull 32:127-132
19. Bodnár M, Hartmann JF, Borbély J (2005) Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules 6:2521-2527
20. Bodnár M, Hartmann JF, Borbély J (2006) Synthesis and study of cross-linked chitosan-N-poly(ethylene glycol) nanoparticles. Biomacromolecules 7:3030-3036
21. Minko T, Kopeckova P, Pozharov V, Kopecek J (1998) HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. J Controlled Release 54:223-233
22. Minko T, Kopeckova P, Kopecek J (1999) Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line. J Controlled Release 59:133-148
23. Pakunlu RI, Cook TJ, Minko T (2003) Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin. Pharm Res 20:351-359
24. Dharap SS, Chandna P, Wang Y, Khandare JJ, Qiu B, Stein S, Minko T (2006) Molecular targeting of BCL2 and BCLXL proteins by synthetic BH3 peptide enhances the efficacy of chemotherapy. J Pharmacol Exp Ther 316:992-998
25. Khandare JJ, Chandna P, Wang Y, Pozharov VP, Minko T (2006) Novel polymeric prodrug with multivalent components for cancer therapy. J Pharmacol Exp Ther 317:929-937
26. Khandare JJ, Jayant S, Singh S, Chandna P, Wang Y, Vorsa N, Minko T (2006) Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of Paclitaxel. Bioconjug Chem 17:1464-1472
27. Dharap SS, Wang Y, Chandna P, Khandare JJ, Qiu B, Gunaseelan S, Sinko PJ, Stein S, Farmanfarmaian A, Minko T (2005) Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc Natl Acad Sci USA 102:12962-12967
28. Pakunlu RI, Wang Y, Saad M, Khandare JJ, Starovoytov V, Minko T (2006) In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug. J Controlled Release 114:153-162
29. Hong S, Leroueil PR, Majoros IJ, Orr BG, Baker JR Jr, Banasak Holl MM (2007) The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem Biol 14:P107-P115
30. Kang HS, Park SH, Lee YG, Son TI (2007) Polyelectrolyte complex hydrogel composed of chitosan and poly(γ-glutamic acid) for biological application: Preparation, physical properties, and cytocompatibility. J Appl Polym Sci 103(1):386-394
31. Bhumkar DR, Pokharkar VB (2006) Studies on effect of pH on cross-linking of chitosan with sodium tripolyphosphate: A technical note. AAPS PharmSciTech 7(2):138-143
32. Novak L, Banyai I, Fleischer-Radu JE, Borbely J (2007) Direct amidation of poly(γ-glutamic acid) with benzylamine in dimethyl sulfoxide. Biomacromolecules 8:1624-1632